Tapinarof cream versus steroid cream for moderate psoriasis
Treatments studied
Part of Skin clinical trials.
This trial compares a new topical cream called tapinarof against a standard steroid cream (betamethasone) for treating moderate plaque psoriasis. Researchers want to see which treatment works better and is safer for people with psoriasis affecting a limited area of skin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–65 years
- Diagnosed plaque psoriasis covering 2–20% of your body (mild to moderate, not severe)
- Psoriasis for at least 6 months
- Willing to stop other psoriasis treatments for 2 weeks before starting (or not currently using them)
- No pregnancy or breastfeeding
- No severe allergies to tapinarof or betamethasone
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new ointment (XJH05) for people with mild-to-moderate plaque psoriasis. It aims to see if this treatment helps reduce symptoms and is safe for topical use.
This trial tests two oral medications, Apremilast and Methotrexate, to see which works better for people with moderate to severe plaque psoriasis. You must not have taken systemic treatments (pills or shots that work throughout the body) in the last 3 months.
This study tests if a cream called tapinarof can improve skin symptoms in people with chronic or subacute cutaneous lupus erythematosus (CLE). The goal is to see if it reduces redness, scaling, and thickness of active lesions.
This trial tests a new topical cream for people with mild or moderate plaque psoriasis. It aims to see if the cream can improve psoriasis patches on the skin.
This study tests a cream for psoriasis to see if it helps prevent or reduce changes in skin color (dark or light patches) that can happen after psoriasis clears. It may be a good fit if you have medium to dark skin and your psoriasis is stable.
This early study tests whether taking vitamin D together with triamcinolone (a steroid used on skin) works better for plaque psoriasis than a standard approach. It aims to see if the combination helps clear psoriasis plaques and is safe.
Hear when a new Psoriasis (PsO) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.